News
CNTB
1.340
-1.47%
-0.020
Weekly Report: what happened at CNTB last week (0415-0419)?
Weekly Report · 5d ago
Pfizer-Connect Biopharma deal for anti-inflammatory agent ends
Seeking Alpha · 04/17 17:27
Connect Biopharma Price Target Raised to $8.00/Share From $7.00 by HC Wainwright & Co.
Dow Jones · 04/17 10:50
Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 04/17 10:50
HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8
Benzinga · 04/17 10:40
Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)
TipRanks · 04/17 10:20
Connect Biopharma Triumphs with Rademikibart Trials
TipRanks · 04/16 21:27
Connect Biopharma GAAP EPS of -$2.15 misses by $1.33
Seeking Alpha · 04/16 20:31
Connect Biopharma Hldgs FY EPS $(1.08) Up From $(2.15) YoY
Benzinga · 04/16 20:22
CONNECT BIOPHARMA HOLDINGS : CASH, CASH EQUIVALENTS & SHORT-TERM INVESTMENTS OF $118.7 MLN EXPECTED TO SUPPORT PLANNED OPERATIONS INTO AT LEAST 2026
Reuters · 04/16 20:05
CONNECT BIOPHARMA REPORTS FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 04/16 20:05
Weekly Report: what happened at CNTB last week (0408-0412)?
Weekly Report · 04/15 11:58
Buy Rating Reaffirmed for Connect Biopharma Holdings Amid Promising Clinical Trials and Strategic Partnerships
TipRanks · 04/10 06:17
Weekly Report: what happened at CNTB last week (0401-0405)?
Weekly Report · 04/08 12:04
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares rose 14.0% to $0.52 during Wednesday's after-market session. Kineta shares rose 8.46% and Simulations Plus shares increased by 6.74%. The company's market cap stands at $24.9 million.
Benzinga · 04/03 20:31
MMAT, CNTB and HGAS among mid-day movers
On the Move MMAT, CNTB and HGAS among mid-day movers. Gainers: Vast Renewables Ltd (VSTE) and Meta Materials. Losers: Eiger BioPharmaceuticals, AEON, MNY, VSTE, LPA.
Seeking Alpha · 04/01 16:57
Weekly Report: what happened at CNTB last week (0325-0329)?
Weekly Report · 04/01 12:01
Weekly Report: what happened at CNTB last week (0318-0322)?
Weekly Report · 03/25 12:04
Weekly Report: what happened at CNTB last week (0311-0315)?
Weekly Report · 03/18 12:02
Weekly Report: what happened at CNTB last week (0304-0308)?
Weekly Report · 03/11 11:57
More
Webull provides a variety of real-time CNTB stock news. You can receive the latest news about Connect Biopharma Holdings Ltd through multiple platforms. This information may help you make smarter investment decisions.
About CNTB
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of T cell-driven inflammatory diseases. The Company’s lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha (IL-4Ra) in development for the treatment of atopic dermatitis and asthma. Its second advanced product candidate, CBP-307, is a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis (UC). The Company’s third product candidate, CBP-174, is a peripherally acting antagonist of histamine receptor 3, in development for the treatment of pruritus associated with atopic dermatitis (AD). It has clinical development activities in the United States, the People’s Republic of China (PRC), Europe, and Australia and operations in those geographies, as well as Hong Kong. Its subsidiaries include Connect Biopharma HongKong Limited, Connect Biopharm LLC and others.